Insider Transactions in Q2 2018 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2018)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 04
2018
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,638
+5.89%
|
$104,832
$64.1 P/Share
|
Jun 04
2018
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,725
+14.73%
|
$110,400
$64.1 P/Share
|
Jun 04
2018
|
Alecia A Decoudreaux Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,638
+50.0%
|
$104,832
$64.1 P/Share
|
Jun 04
2018
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,638
+12.91%
|
$104,832
$64.1 P/Share
|
Jun 04
2018
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,446
+3.92%
|
$284,544
$64.1 P/Share
|
Jun 04
2018
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,638
+50.0%
|
$104,832
$64.1 P/Share
|
Jun 04
2018
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,638
+50.0%
|
$104,832
$64.1 P/Share
|
May 04
2018
|
C David Brown Ii Director |
BUY
Open market or private purchase
|
Direct |
10,000
+8.99%
|
$610,000
$61.99 P/Share
|
May 04
2018
|
David W Dorman Director |
BUY
Open market or private purchase
|
Direct |
24,300
+18.85%
|
$1,506,600
$62.22 P/Share
|
Apr 01
2018
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
25,498
-7.17%
|
$1,580,876
$62.21 P/Share
|
Apr 01
2018
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,351
-14.58%
|
$269,762
$62.21 P/Share
|
Apr 01
2018
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,629
-14.45%
|
$286,998
$62.21 P/Share
|
Apr 01
2018
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,162
-9.3%
|
$134,044
$62.21 P/Share
|
Apr 01
2018
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
594
-1.4%
|
$36,828
$62.21 P/Share
|
Apr 01
2018
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,047
-4.56%
|
$250,914
$62.21 P/Share
|